Vanda Pharmaceuticals, headquartered in Rockville, Md., manufactures a range of prescription drugs. The company develops drugs for various diseases, such as insomnia and schizophrenia. It has expertise in the areas of pharmacogenetics and pharmacogenomics. The company has developed various biochemicals, such as Iloperidone, an antipsychotic and VEC-162, which is melatonin agonist under development for the treatment of sleep disorders. It conducts several clinical trials for development of medicines. The company has an on-site laboratory and a staff of trained professionals. The company s Web site provides information of its stock prices. It also provides analyst coverage for investors.